Patent applications and USPTO patent grants for Bogdan; Andrew.The latest application filed is for "modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use".
Patent | Date |
---|---|
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20220213041 - Bogdan; Andrew ;   et al. | 2022-07-07 |
Bromodomain Inhibitors App 20210253551 - Bogdan; Andrew ;   et al. | 2021-08-19 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20210238159 - Altenbach; Robert J. ;   et al. | 2021-08-05 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,988,454 - Altenbach , et al. April 27, 2 | 2021-04-27 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,981,890 - Altenbach , et al. April 20, 2 | 2021-04-20 |
Tetracyclic Bromodomain Inhibitors App 20210070756 - Fidanze; Steven D. ;   et al. | 2021-03-11 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,844,041 - Altenbach , et al. November 24, 2 | 2020-11-24 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,844,042 - Altenbach , et al. November 24, 2 | 2020-11-24 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,829,473 - Altenbach , et al. November 10, 2 | 2020-11-10 |
Tetracyclic Bromodomain Inhibitors App 20200291027 - Fidanze; Steven D. ;   et al. | 2020-09-17 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277276 - Altenbach; Robert J. ;   et al. | 2020-09-03 |
Modulators Of The Cystic Fibrosis Transmembrane Conductance Regulator Protein And Methods Of Use App 20200277275 - Altenbach; Robert J. ;   et al. | 2020-09-03 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277274 - Altenbach; Robert J. ;   et al. | 2020-09-03 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277273 - Altenbach; Robert J. ;   et al. | 2020-09-03 |
Heteroaryl substituted pyridines and methods of use Grant 10,604,515 - Altenbach , et al. | 2020-03-31 |
Bromodomain Inhibitors App 20200048220 - Bogdan; Andrew ;   et al. | 2020-02-13 |
Tetracyclic Bromodomain Inhibitors App 20190389861 - Fidanze; Steven D. ;   et al. | 2019-12-26 |
Substituted Pyrrolidines and Methods of Use App 20190315687 - Altenbach; Robert J. ;   et al. | 2019-10-17 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,428,017 - Altenbach , et al. October 1, 2 | 2019-10-01 |
Substituted pyrrolidines and methods of use Grant 10,399,940 - Altenbach , et al. Sep | 2019-09-03 |
Substituted Tricyclics and Method of Use App 20190135827 - Altenbach; Robert J. ;   et al. | 2019-05-09 |
Substituted Chromanes and Method of Use App 20190127356 - Altenbach; Robert J. ;   et al. | 2019-05-02 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20190077784 - Altenbach; Robert J. ;   et al. | 2019-03-14 |
Heteroaryl Substituted Pyridines and Methods of Use App 20190055229 - Altenbach; Robert J. ;   et al. | 2019-02-21 |
Bromodomain Inhibitors App 20190008866 - Bogdan; Andrew ;   et al. | 2019-01-10 |
Heteroaryl substituted pyridines and methods of use Grant 10,138,227 - Altenbach , et al. Nov | 2018-11-27 |
6-heteroaryloxy- Or 6-aryloxy-quinoline-2-carboxamides And Method Of Use App 20180334435 - Bogdan; Andrew ;   et al. | 2018-11-22 |
Modulators of cystic fibrosis transmembrane conductance regulator protein Grant 10,118,916 - Altenbach , et al. November 6, 2 | 2018-11-06 |
Tetracyclic Bromodomain Inhibitors App 20180298003 - Fidanze; Steven D. ;   et al. | 2018-10-18 |
Bromodomain inhibitors Grant 10,085,985 - Bogdan , et al. October 2, 2 | 2018-10-02 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20180244640 - Altenbach; Robert J. ;   et al. | 2018-08-30 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20180244611 - Altenbach; Robert J. ;   et al. | 2018-08-30 |
Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors Grant 10,035,800 - Fidanze , et al. July 31, 2 | 2018-07-31 |
Substituted pyrrolidines and methods of use Grant 9,981,910 - Altenbach , et al. May 29, 2 | 2018-05-29 |
6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use Grant 9,969,693 - Bogdan , et al. May 15, 2 | 2018-05-15 |
Substituted Pyrrolidines and Methods of Use App 20180099932 - Altenbach; Robert J. ;   et al. | 2018-04-12 |
Substituted Pyrrolidines and Methods of Use App 20180099931 - Altenbach; Robert J. ;   et al. | 2018-04-12 |
Substituted Tricyclics and Method of Use App 20180037587 - Altenbach; Robert J. ;   et al. | 2018-02-08 |
Substituted tricyclics and method of use Grant 9,840,513 - Altenbach , et al. December 12, 2 | 2017-12-12 |
Heteroaryl Substituted Pyridines And Methods Of Use App 20170349576 - Altenbach; Robert J. ;   et al. | 2017-12-07 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator Protein App 20170305891 - Altenbach; Robert J. ;   et al. | 2017-10-26 |
6-heteroaryloxy- Or 6-aryloxy-quinoline-2-carboxamides And Method Of Use App 20170226062 - Bogdan; Andrew ;   et al. | 2017-08-10 |
Substituted Chromanes And Method Of Use App 20170190693 - Altenbach; Robert J. ;   et al. | 2017-07-06 |
Substituted chromanes and method of use Grant 9,642,831 - Altenbach , et al. May 9, 2 | 2017-05-09 |
Substituted Tricyclics And Method Of Use App 20170015675 - Altenbach; Robert J. ;   et al. | 2017-01-19 |
6-heteroaryloxy- Or 6-aryloxy-quinoline-2-carboxamides And Method Of Use App 20160355482 - Bogdan; Andrew ;   et al. | 2016-12-08 |
Bromodomain Inhibitors App 20160331749 - Bogdan; Andrew ;   et al. | 2016-11-17 |
6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use Grant 9,452,986 - Bogdan , et al. September 27, 2 | 2016-09-27 |
Bromodomain inhibitors Grant 9,428,514 - Bogdan , et al. August 30, 2 | 2016-08-30 |
Substituted Chromanes And Method Of Use App 20160120841 - Kym; Philip R. ;   et al. | 2016-05-05 |
Tetracyclic Bromodomain Inhibitors App 20160039821 - Fidanze; Steven D. ;   et al. | 2016-02-11 |
6-heteroaryloxy- Or 6-aryloxy-quinoline-2-carboxamides And Method Of Use App 20150218102 - Bogdan; Andrew ;   et al. | 2015-08-06 |
Bromodomain Inhibitors App 20150158873 - Bogdan; Andrew ;   et al. | 2015-06-11 |
Bromodomain Inhibitors App 20150150884 - Liu; Dachun ;   et al. | 2015-06-04 |
Bromodomain inhibitors Grant 8,980,879 - Liu , et al. March 17, 2 | 2015-03-17 |
Bromodomain Inhibitors App 20140256710 - Liu; Dachun ;   et al. | 2014-09-11 |
Glycyrrhetinic Acid Derivatives And Methods Of Use Thereof App 20140073700 - Wagner; Rolf ;   et al. | 2014-03-13 |
Method and apparatus for continuous flow synthesis of ibuprofen Grant 8,426,630 - McQuade , et al. April 23, 2 | 2013-04-23 |
Method And Apparatus For Continuous Flow Synthesis Of Ibuprofen App 20110054208 - McQuade; D. Tyler ;   et al. | 2011-03-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.